An observational study in Any Conditions, sponsored by University Hospital, Bordeaux. Completed at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-03-06.
Sponsored by University Hospital, Bordeaux · Observational
Non-appropriateness of care is a common and serious phenomenon that affects healthcare institutions in France. Appropriateness in health care is about adequacy of any type of health care with patient's needs. Relying on structuring innovative tools, the hospital university centre of Bordeaux is implementing a health care appropriateness assessment and support programme ("sPREAd pertinence").
By using a mixed method, the project's main objective is to evaluate programme effectiveness on the improvement of care appropriateness in hospital university centre of Bordeaux. Other assessments are considering impact on: specific care appropriateness indicators, care related adverse events frequency, organizational climate, and work life satisfaction. The economic impact of this program in terms of induced costs and avoided costs will be evaluated. A qualitative approach will be used to identify the programme transferability conditions with a view to produce an Operational Model for the Implementation of Appropriateness at a Healthcare Institution.
Non-appropriateness of care is a common and serious phenomenon that affects healthcare institutions in France. Appropriateness in health care is about adequacy of any type of health care with patient's needs. It means that a health care is necessary and relevant, given a specific indication, with regard to updated practice recommendations or justifications of experts.
The hospital university centre of Bordeaux is making Health care appropriateness a policy priority. Relying on structuring innovative tools, it is implementing a health care appropriateness assessment and support programme ("sPREAd pertinence"). This programme comprises two parts, one regarding interventional aspects and the other concerning assessments.
sPREAd-Pertinence programme's objectives Project's primary objective is to evaluate programme effectiveness on the improvement of care appropriateness in hospital university centre of Bordeaux.
Project's secondary objectives are :
to identify, using a qualitative approach:
Qualitative section of the project will analyse the mechanisms of program effectiveness using an exploratory approach based on semi-structured interviews and direct observations of PAG.
Global proportion of patient stays appropriate regarding health cares concerned with feedback indicators available at the start of the trial.
University Hospital, Bordeaux is the lead sponsor of 783 studies on the registry; 188 are open to participants now.
Counted across the registry records on this site, refreshed daily.
There are 3 study populations in this trial: - Health care professionals : medical and paramedical staffs - Patients - Hospital stays
Exclusion Criteria:
Services of the non-transversal clinical departments of the Bordeaux University Hospital willing to participate to the programme.
Other: Intervention
Services of the non-transversal clinical departments of the Bordeaux University Hospital not willing to participate to the programme.
The program intervention has three focuses : the prioritization of appropriateness indicators, the automation and visualization of the prioritized indicators, and support for practice analysis groups (PAG) based on e-feedback from automated indicators
Global proportion of patient stays appropriate regarding health cares concerned with feedback indicators available at the start of the trial.
This proportion is calculated by dividing the number of appropriate patient stays for all indicators corresponding to targeted health care by the number of patients who received targeted health care for at least one of the indicators.
Time frame: Primary outcome is assessed 14 months after the start of the intervention
Appropriate stays proportion specific to each feedback indicator available at the start of the trial
Appropriate stays proportion specific to each feedback indicator available at the start of the trial is calculated as the number of stays appropriate according to the indicator (numerator) over the number of stays concerned by the indicator (denominator);
Time frame: two months before and fourteen months after applying the programme in the first cluster.
Incidence density of serious adverse events
Incidence density of serious adverse events measured by a specific data collection in each service using the questionnaires tested in the two France National Surveys on Adverse Events in Healthcare (ENEIS 1 and ENEIS 2);
Time frame: two months before and fourteen months after applying the programme in the first cluster.
Dimension Scores of the Comet questionnaire
Dimension Scores of the Comet ("Contexte Organisationnel et Managérial en Etablissement de santé" / Organizational and Managerial Context in Healthcare Establishments) questionnaire measuring the Organizational Climate (for each dimension, proportion of professionals giving the answers "completely agree" or "agree");
Time frame: two months before and fourteen months after applying the programme in the first cluster.
Work life satisfaction
Work life satisfaction score measured by the validated ESVP ("Echelle de Satisfaction globale de Vie Professionnelle" / global professional life satisfaction scale) questionnaire. It consists of 5 items and assesses the overall satisfaction of individuals with their work life. This score is calculated by summing the responses to each of the 5 items. The answers materialize a position on a scale of agreement going from "1" (Not at all in agreement) to "7" (Totally in agreement). The possible range of scores on this scale can thus oscillate from 5 (low satisfaction) to 35 (high satisfaction). The higher the score, the greater the perceived satisfaction with work life.
Time frame: two months before and fourteen months after applying the programme in the first cluster.
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Hospital, Bordeaux